Home > Insider Trading > Filing (0001123292-19-000748)

Filing Details

Accession Number:: 0001123292-19-000748
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-05-13 19:32:00
Reporting Period:: 2019-05-13

Accepted Time:: 2019-05-13 19:32:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1661059	Nextcure Inc.	NXTC	()	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1055951	Orbimed Advisors Llc	C/O Nextcure, Inc. 9000 Virginia Manor Road, Suite 200 Beltsville MD 20705		Yes	No	Yes	No
1682115	Orbimed Capital Gp Vi Llc	C/O Nextcure, Inc. 9000 Virginia Manor Road, Suite 200 Beltsville MD 20705		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-05-13	445,866	$0.00	445,866	No	4	C	Indirect	By OrbiMed Private Investments VI, LP
Common Stock	Acquisiton	2019-05-13	743,110	$0.00	1,188,976	No	4	C	Indirect	By OrbiMed Private Investments VI, LP
Common Stock	Acquisiton	2019-05-13	729,599	$0.00	1,918,575	No	4	C	Indirect	By OrbiMed Private Investments VI, LP
Common Stock	Acquisiton	2019-05-13	442,438	$0.00	2,361,013	No	4	C	Indirect	By OrbiMed Private Investments VI, LP
Common Stock	Acquisiton	2019-05-13	350,000	$15.00	2,711,013	No	4	P	Indirect	By OrbiMed Private Investments VI, LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By OrbiMed Private Investments VI, LP
No	4	C	Indirect	By OrbiMed Private Investments VI, LP
No	4	C	Indirect	By OrbiMed Private Investments VI, LP
No	4	C	Indirect	By OrbiMed Private Investments VI, LP
No	4	P	Indirect	By OrbiMed Private Investments VI, LP

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A-1 Preferred Stock	Disposition	2019-05-13	3,582,000	$0.00	445,866	$0.00
Common Stock	Series A-2 Preferred Stock	Disposition	2019-05-13	5,970,000	$0.00	743,110	$0.00
Common Stock	Series A-3 Preferred Stock	Disposition	2019-05-13	5,861,455	$0.00	729,599	$0.00
Common Stock	Series B-1 Preferred Stock	Disposition	2019-05-13	3,554,466	$0.00	442,438	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date.
These securities are held of record by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the sole general partner of OPI VI, and OrbiMed Advisors LLC ("OrbiMed Advisors") may be deemed to have voting and investment power with respect to the shares held by OPI VI and as a result may be deemed to have beneficial ownership of such shares. OrbiMed Advisors exercises investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho and Jonathan T. Silverstein.
This report on Form 4 is jointly filed by GP VI and OrbiMed Advisors. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. The Reporting Persons have designated a representative, currently Chau Q. Khuong ("Khuong"), an employee of OrbiMed advisors, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any of the Reporting Persons or Khuong is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or any other purpose.